Sabina Stawicki
Max Planck Society(DE)Max Planck Institute of Experimental Medicine(DE)
Publications by Year
Research Areas
Schizophrenia research and treatment, Substance Abuse Treatment and Outcomes, Psychiatric care and mental health services, Tryptophan and brain disorders, Erythropoietin and Anemia Treatment
Most-Cited Works
- → Improvement of cognitive functions in chronic schizophrenic patients by recombinant human erythropoietin(2006)259 cited
- → Follow‐up of 180 Alcoholic Patients for up to 7 Years After Outpatient Treatment: Impact of Alcohol Deterrents on Outcome(2006)97 cited
- → Modification of Cognitive Performance in Schizophrenia by Complexin 2 Gene Polymorphisms(2010)96 cited
- → Recombinant human erythropoietin delays loss of gray matter in chronic schizophrenia(2010)94 cited
- → RECOVERY OF HIPPOCAMPUS-RELATED FUNCTIONS IN CHRONIC ALCOHOLICS DURING MONITORED LONG-TERM ABSTINENCE(2006)73 cited
- → Recombinant Human Erythropoietin in the Treatment of Human Brain Disease: Focus on Cognition(2007)54 cited
- → Substantial decrease of psychiatric comorbidity in chronic alcoholics upon integrated outpatient treatment – results of a prospective study(2004)53 cited
- → Personality Disorder and Chronicity of Addiction as Independent OutcomePredictors in Alcoholism Treatment(2006)47 cited
- → Outpatient Long-term Intensive Therapy for Alcoholics (OLITA): a successful biopsychosocial approach to the treatment of alcoholism(2007)29 cited
- → Episode-Specific Differential Gene Expression of Peripheral Blood Mononuclear Cells in Rapid Cycling Supports Novel Treatment Approaches(2008)28 cited